SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-037193
Filing Date
2023-11-07
Accepted
2023-11-07 08:42:56
Documents
81
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20230930.htm   iXBRL 10-Q 1430955
2 EX-10.1 exhibit101-amendmentno1tor.htm EX-10.1 13414
3 EX-10.2 exhibit102-amendmentno2tor.htm EX-10.2 35615
4 EX-10.3 exhibit103-aprotopapasreti.htm EX-10.3 88845
5 EX-10.4 exhibit104-mhuberofferlett.htm EX-10.4 91526
6 EX-10.5 exhibit105-ayangletteragre.htm EX-10.5 55740
7 EX-31.1 exhibit31110-qfy2023q3.htm EX-31.1 11101
8 EX-31.2 exhibit31210-qfy2023q3.htm EX-31.2 11101
9 EX-32.1 exhibit32110-qfy2023q3.htm EX-32.1 5730
15 mrsnlogo.gif GRAPHIC 8511
16 mrsnlogob.gif GRAPHIC 8511
  Complete submission text file 0001628280-23-037193.txt   6604522

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20230930.xsd EX-101.SCH 41957
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20230930_cal.xml EX-101.CAL 49044
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20230930_def.xml EX-101.DEF 204394
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20230930_lab.xml EX-101.LAB 496731
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20230930_pre.xml EX-101.PRE 356431
75 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20230930_htm.xml XML 787152
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 231381840
SIC: 2834 Pharmaceutical Preparations